Viranga Tillekeratne
Inventor
Stats
- 3 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 8 US Applications Filed
- 5 Total Citation Count
- Aug 28, 2023 Most Recent Filing
- Jul 20, 2006 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| THE UNIVERSITY OF TOLEDO | 2
2 2 1 | 2006
2008 2014 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Toledo, OH, US | Oct 15, 09 - Apr 04, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0109,852 | 2024 | Ferroptosis-HDAC Inhibitor Hybrid Anticancer Agents | 0 |
| 11548850 | 2023 | Development of a cofilin inhibitor for the treatment of hemorrhagic brain injury-induced neuroinflammation | 0 |
| 11098038 | 2021 | Imidazole-based anticancer agents and derivatives thereof, and methods of making and using same | 0 |
| 2020/0385,374 | 2020 | IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME | 0 |
| 2020/0369,603 | 2020 | Development of a Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury-Induced Neuroinflammation | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.